Skip to main content
Chronic Wound Care Market Analysis North America, Europe, Asia, Rest of World (ROW) - US, Germany, UK, France, Japan - Size and Forecast 2024-2028

Chronic Wound Care Market Analysis North America, Europe, Asia, Rest of World (ROW) - US, Germany, UK, France, Japan - Size and Forecast 2024-2028

Published: Dec 2023 166 Pages SKU: IRTNTR76997

Market Overview at a Glance

$5.44 B
Market Opportunity
6.52%
CAGR
5.68
YoY growth 2023-2024(%)

Chronic Wound Care Market Size 2024-2028 

The chronic wound care market size is forecast to increase by USD 5.44 billion at a CAGR of 6.52% between 2023 and 2028.

  • Chronic wounds, including surgical wounds and trauma wounds, pose a significant challenge to healthcare systems due to their prevalence and high treatment costs. Factors such as wound infections, compromised immune function, and poor circulation contribute to the complexity of managing these wounds. In response, the market for chronic wound care solutions is witnessing notable trends, including the increasing adoption of advanced wound care technologies like moist wound dressings. Hospitals and specialty clinics are integrating wound care teams to improve patient outcomes and reduce healthcare costs. However, the high expense of chronic wound treatment remains a significant challenge for both providers and patients.

What will be the Size of the Market During the Forecast Period?

Chronic Wound Care Market Size

 Request Free Sample

  • The market represents a significant and growing segment within the healthcare industry. Chronic wounds, such as those resulting from diabetes, pressure ulcers, venous ulcers, arterial ulcers, and other chronic diseases including cancer and autoimmune diseases, present unique challenges for effective treatment and healing. Chronic diseases, including diabetes, are a leading cause of chronic wounds. Diabetes-related foot ulcers alone account for a substantial portion of chronic wounds, with an estimated 15% of people with diabetes developing a foot ulcer at some point in their lives.
  • Another significant contributor to chronic wounds is the changing lifestyle trends, leading to an increase in obesity, sedentary lifestyles, and unhealthy diets. These factors can result in a higher incidence of chronic wounds, particularly pressure ulcers, which affect individuals with limited mobility and those requiring extended hospital stays. The rising prevalence of chronic wounds is driving demand for advanced wound care solutions. Medical devices, such as medical tapes, bandages, and wound dressings, play a crucial role in the treatment and management of chronic wounds. These products are designed to promote wound healing, protect against infection, and provide a comfortable and secure covering for the wound.

How is this market segmented and which is the largest segment?

The market research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in "USD billion" for the period 2024-2028, as well as historical data from 2018-2022 for the following segments.

  • Product
    • Advanced dressing
    • Traditional wound care
    • Surgical wound care
    • Wound therapy devices
  • Application
    • Diabetic foot ulcers
    • Pressure ulcers
    • Venous leg ulcers
  • Geography
    • North America
      • US
    • Europe
      • Germany
      • UK
      • France
    • Asia
      • Japan
    • Rest of World (ROW)

By Product Insights

  • The advanced dressing segment is estimated to witness significant growth during the forecast period.

In the realm of chronic wound care, various supplies play a pivotal role in ensuring optimal healing. Among these, sterilization supplies and hand sanitizers are essential for maintaining a clean and hygienic environment. Obesity is a significant contributor to chronic wounds, particularly in the form of lower extremity amputations. Advanced wound dressings, such as hydrocolloid, gel, film, alginate, and foam dressings, are utilized to protect the surrounding tissue and wound base. These dressings absorb exudate or hold onto moisture, enabling the wound to heal effectively. Advanced wound dressings, like alginate, offer high absorbency and transform into a gel upon contact with the wound surface.

Furthermore, this gel can be effortlessly removed with a dressing or washed off with sterile saline. Traditional wound dressings and surgical wound dressings also hold importance in wound care. Wound therapy devices, such as negative pressure wound therapy and electrical stimulation, further enhance the healing process. The market for chronic wound care supplies is segmented into the hospital segment and home healthcare segment. The hospital segment accounts for a larger share due to the availability of advanced medical facilities and specialized care. The home healthcare segment is expected to witness significant growth due to the increasing trend of home-based healthcare and the convenience it offers to patients.

Chronic Wound Care Market Size

Get a glance at the market report of share of various segments Request Free Sample

The advanced dressing segment was valued at USD 4.41 billion in 2018 and showed a gradual increase during the forecast period.

Regional Analysis

  • North America is estimated to contribute 44% to the growth of the global market during the forecast period.

Technavio's analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period.

Chronic Wound Care Market Share by Geography

For more insights on the market share of various regions Request Free Sample

In North America, the market is experiencing significant growth due to the rising number of individuals with chronic, non-healing wounds. Factors contributing to this trend include an aging population, increased prevalence of chronic health conditions such as diabetes and obesity, and an uptick in accidents and surgeries. To address these complex needs, manufacturers of medical devices and healthcare providers are focusing on developing advanced products and treatments that enhance wound healing and minimize costs. Innovations like the use of bioactive materials and smart dressings have significantly improved chronic wound care, among other technological advancements. The industry's expansion is essential in reducing hospital admissions and improving the quality of life for those affected by acute and chronic wounds.

Market Dynamics

Our researchers analyzed the data with 2023 as the base year, along with the key drivers, trends, and challenges. A holistic analysis of drivers will help companies refine their marketing strategies to gain a competitive advantage.

What are the key market drivers leading to the rise in the adoption of the Chronic Wound Care Market?

The rising prevalence of chronic wounds is the key driver of the market.

  • The market in the US is experiencing notable expansion due to the increasing prevalence of chronic wounds, which can last for over three months. Chronic wounds are commonly associated with various conditions such as diabetes, sports injuries, autoimmune diseases, cancer, and obesity. Diabetic foot ulcers, for instance, develop in people with diabetes, often due to nerve damage and poor circulation. These ulcers can worsen if left untreated, leading to potential complications like lower extremity amputations. Moreover, chronic diseases like pressure ulcers, venous ulcers, arterial ulcers, and diabetic ulcers are also significant contributors to the market's growth. Advanced wound dressings, medical tapes, bandages, drug delivery products, respiratory supplies, sterilization supplies, and hand sanitizers are some of the essential wound care products in demand.
  • The market is segmented into hospitals and home healthcare, with surgical procedures being a significant driver for the hospital segment. In-home care settings, patient support programs and traditional wound care techniques are prevalent. Wound therapy devices like Negative Pressure Wound Therapy (NPWT) systems and foam dressings are increasingly popular due to their ability to maintain a moist wound environment and prevent excessive moisture buildup. Factors like changing lifestyles, increasing chronic health conditions, and accidents contribute to the rising number of chronic wound cases. Additionally, medical tourism and the geriatric population's growing needs further fuel market growth. The active therapy and bioactive therapy segments are gaining traction due to their effectiveness in promoting the healing process.

What are the market trends shaping the Chronic Wound Care Market?

Increasing adoption of advanced wound care technologies is the upcoming trend in the market.

  • The market in the US is experiencing a notable shift towards the utilization of advanced wound care technologies. Factors fueling this trend include the escalating prevalence of chronic wounds, the expanding geriatric population, and the demand for enhanced treatment modalities. Chronic wounds, such as diabetic foot ulcers, pressure ulcers, and venous leg ulcers, pose a substantial healthcare concern due to their complex nature and potential complications. These complications can lead to pain, disability, and diminished quality of life for patients. In response, specialized wound care centers have emerged, offering targeted treatments to expedite the healing process. Advanced wound care technologies encompass a range of products and techniques, including medical tapes, bandages, drug delivery systems, respiratory supplies, sterilization supplies, hand sanitizers, and various types of wound dressings.
  • These innovations cater to the unique needs of chronic wounds, addressing issues like autoimmune diseases, obesity, lower extremity amputations, and compromised immune function or poor circulation. The market is segmented into the hospital and home healthcare sectors, with surgical procedures and medical tourism also playing a role in its growth. Active therapies and bioactive therapies, such as foam dressings, moist wound environments, and advanced wound dressing materials, are increasingly being adopted to optimize the healing process. The market is further driven by the rising number of chronic health conditions and lifestyle factors contributing to chronic wound cases, as well as trauma cases and patient support programs.

What challenges does the Chronic Wound Care Market face during its growth?

The high cost of chronic wound treatment is a key challenge affecting the market growth.

  • Chronic wounds, such as those resulting from sports injuries, diabetes, changing lifestyles leading to obesity, and chronic diseases like cancer and autoimmune diseases, require specialized and prolonged care. The treatment process for chronic wounds involves various interventions, including wound assessment, infection control, debridement, offloading, and the use of advanced wound dressings, medical tapes, bandages, drug delivery products, respiratory supplies, sterilization supplies, and hand sanitizers. These interventions often need to be repeated over an extended period, leading to increased costs. One significant contributor to the high cost of chronic wound care is the need for specialized healthcare professionals, such as wound care teams, who possess expertise in managing these complex conditions.
  • Their extensive training and experience add to the overall cost. Additionally, the use of advanced wound therapy devices, such as Negative Pressure Wound Therapy (NPWT) systems, foam dressings, and moist wound dressings, also contributes to the high cost. Moreover, chronic wounds, including diabetic foot ulcers, pressure ulcers, venous ulcers, arterial ulcers, and surgical wounds, can lead to lower extremity amputations, hospital admissions, and increased healthcare services utilization. The high prevalence of chronic health conditions and lifestyle factors, such as obesity and accidents, contribute to the increasing number of chronic wound cases. In the US market, the market caters to the needs of various end-users, including hospitals and specialty clinics.

Exclusive Customer Landscape

The market forecasting report includes the adoption lifecycle of the market, covering from the innovator's stage to the laggard's stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the market report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their market growth analysis strategies.

Chronic Wound Care Market Share by Geography

 Customer Landscape

Key Companies & Market Insights

Companies are implementing various strategies, such as strategic alliances, market forecast, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market.

The market research and growth report includes detailed analyses of the competitive landscape of the market and information about key companies, including:

  • 3M Co.
  • B.Braun SE
  • Baxter Regional Medical Center
  • Bioventus LLC
  • Brightwake Ltd.
  • Cardinal Health Inc.
  • Coloplast AS
  • ConvaTec Group Plc
  • Essity AB
  • Integra Lifesciences Corp.
  • Johnson and Johnson
  • Medline Industries LP
  • Medtronic Plc
  • Mil Laboratories Pvt. Ltd.
  • MiMedx Group Inc.
  • Paul Hartmann AG
  • Smith and Nephew plc
  • Welcare Industries SpA
  • Zimmer Biomet Holdings Inc.
  • DermaRite Industries LLC

Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.

Research Analyst Overview

Chronic wounds, such as those caused by sports injuries, diabetes, changing lifestyles, chronic diseases like cancer and autoimmune diseases, and surgical procedures, can be challenging to heal due to factors like antimicrobial resistance and compromised immune function. Advanced wound care solutions include medical tapes, bandages, drug delivery products, sterilization supplies, and hand sanitizers. These products cater to various end-use segments, including hospitals and home healthcare, and address different types of wounds, such as diabetic foot ulcers, pressure ulcers, and venous ulcers. Active and bioactive therapies, including foam dressings and polymer-based dressings infused with bioactive agents, promote a moist wound environment essential for the healing process.

Furthermore, wound therapy devices, such as negative pressure wound therapy systems, also play a crucial role in managing chronic wounds. In-home care settings, active therapy and bioactive wound care dressings facilitate the healing process for patients with chronic health conditions and lifestyle factors contributing to delayed wound healing. Wound care teams employ various techniques to address trauma cases, surgical wounds, burn injuries, and other chronic wounds, ensuring optimal patient outcomes.

Market Scope

Report Coverage

Details

Page number

166

Base year

2023

Historic period

2018-2022

Forecast period

2024-2028

Growth momentum & CAGR

Accelerate at a CAGR of 6.52%

Market Growth 2024-2028

USD 5.44 billion

Market structure

Fragmented

YoY growth 2023-2024(%)

5.68

Key countries

US, Germany, UK, France, and Japan

Competitive landscape

Leading Companies, Market Positioning of Companies, Competitive Strategies, and Industry Risks

Request Free Sample

What are the Key Data Covered in this Market Research and Growth Report?

  • CAGR of the market during the forecast period
  • Detailed information on factors that will drive the market growth and forecasting between 2024 and 2028
  • Precise estimation of the size of the market  and its contribution of the market in focus to the parent market
  • Accurate predictions about upcoming market growth and trends and changes in consumer behaviour
  • Growth of the market across North America, Europe, Asia, and Rest of World (ROW)
  • Thorough analysis of the market's competitive landscape and detailed information about companies
  • Comprehensive analysis of factors that will challenge the growth of market companies

We can help! Our analysts can customize this market research report to meet your requirements. Get in touch

1 Executive Summary

  • 1.1 Market overview
    • Exhibit 01: Executive Summary – Chart on Market Overview
    • Exhibit 02: Executive Summary – Data Table on Market Overview
    • Exhibit 03: Executive Summary – Chart on Global Market Characteristics
    • Exhibit 04: Executive Summary – Chart on Market by Geography
    • Exhibit 05: Executive Summary – Chart on Market Segmentation by Product
    • Exhibit 06: Executive Summary – Chart on Market Segmentation by Application
    • Exhibit 07: Executive Summary – Chart on Incremental Growth
    • Exhibit 08: Executive Summary – Data Table on Incremental Growth
    • Exhibit 09: Executive Summary – Chart on Vendor Market Positioning

2 Market Landscape

  • 2.1 Market ecosystem
    • Exhibit 10: Parent market
    • Exhibit 11: Market Characteristics

3 Market Sizing

  • 3.1 Market definition
    • Exhibit 12: Offerings of vendors included in the market definition
  • 3.2 Market segment analysis
    • Exhibit 13: Market segments
  • 3.3 Market size 2023
    • 3.4 Market outlook: Forecast for 2023-2028
      • Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
      • Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)

    4 Historic Market Size

    • 4.1 Global chronic wound care market 2018 - 2022
      • Exhibit 18: Historic Market Size – Data Table on global chronic wound care market 2018 - 2022 ($ billion)
    • 4.2 Product Segment Analysis 2018 - 2022
      • Exhibit 19: Historic Market Size – Product Segment 2018 - 2022 ($ billion)
    • 4.3 Application Segment Analysis 2018 - 2022
      • Exhibit 20: Historic Market Size – Application Segment 2018 - 2022 ($ billion)
    • 4.4 Geography Segment Analysis 2018 - 2022
      • Exhibit 21: Historic Market Size – Geography Segment 2018 - 2022 ($ billion)
    • 4.5 Country Segment Analysis 2018 - 2022
      • Exhibit 22: Historic Market Size – Country Segment 2018 - 2022 ($ billion)

    5 Five Forces Analysis

    • 5.1 Five forces summary
      • Exhibit 23: Five forces analysis - Comparison between 2023 and 2028
    • 5.2 Bargaining power of buyers
      • Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2023 and 2028
    • 5.3 Bargaining power of suppliers
      • Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2023 and 2028
    • 5.4 Threat of new entrants
      • Exhibit 26: Threat of new entrants – Impact of key factors in 2023 and 2028
    • 5.5 Threat of substitutes
      • Exhibit 27: Threat of substitutes – Impact of key factors in 2023 and 2028
    • 5.6 Threat of rivalry
      • Exhibit 28: Threat of rivalry – Impact of key factors in 2023 and 2028
    • 5.7 Market condition
      • Exhibit 29: Chart on Market condition - Five forces 2023 and 2028

    6 Market Segmentation by Product

    • 6.1 Market segments
      • Exhibit 30: Chart on Product - Market share 2023-2028 (%)
      • Exhibit 31: Data Table on Product - Market share 2023-2028 (%)
    • 6.2 Comparison by Product
      • Exhibit 32: Chart on Comparison by Product
      • Exhibit 33: Data Table on Comparison by Product
    • 6.3 Advanced dressing - Market size and forecast 2023-2028
      • Exhibit 34: Chart on Advanced dressing - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 35: Data Table on Advanced dressing - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 36: Chart on Advanced dressing - Year-over-year growth 2023-2028 (%)
      • Exhibit 37: Data Table on Advanced dressing - Year-over-year growth 2023-2028 (%)
    • 6.4 Traditional wound care - Market size and forecast 2023-2028
      • Exhibit 38: Chart on Traditional wound care - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 39: Data Table on Traditional wound care - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 40: Chart on Traditional wound care - Year-over-year growth 2023-2028 (%)
      • Exhibit 41: Data Table on Traditional wound care - Year-over-year growth 2023-2028 (%)
    • 6.5 Surgical wound care - Market size and forecast 2023-2028
      • Exhibit 42: Chart on Surgical wound care - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 43: Data Table on Surgical wound care - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 44: Chart on Surgical wound care - Year-over-year growth 2023-2028 (%)
      • Exhibit 45: Data Table on Surgical wound care - Year-over-year growth 2023-2028 (%)
    • 6.6 Wound therapy devices - Market size and forecast 2023-2028
      • Exhibit 46: Chart on Wound therapy devices - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 47: Data Table on Wound therapy devices - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 48: Chart on Wound therapy devices - Year-over-year growth 2023-2028 (%)
      • Exhibit 49: Data Table on Wound therapy devices - Year-over-year growth 2023-2028 (%)
    • 6.7 Market opportunity by Product
      • Exhibit 50: Market opportunity by Product ($ billion)
      • Exhibit 51: Data Table on Market opportunity by Product ($ billion)

    7 Market Segmentation by Application

    • 7.1 Market segments
      • Exhibit 52: Chart on Application - Market share 2023-2028 (%)
      • Exhibit 53: Data Table on Application - Market share 2023-2028 (%)
    • 7.2 Comparison by Application
      • Exhibit 54: Chart on Comparison by Application
      • Exhibit 55: Data Table on Comparison by Application
    • 7.3 Diabetic foot ulcers - Market size and forecast 2023-2028
      • Exhibit 56: Chart on Diabetic foot ulcers - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 57: Data Table on Diabetic foot ulcers - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 58: Chart on Diabetic foot ulcers - Year-over-year growth 2023-2028 (%)
      • Exhibit 59: Data Table on Diabetic foot ulcers - Year-over-year growth 2023-2028 (%)
    • 7.4 Pressure ulcers - Market size and forecast 2023-2028
      • Exhibit 60: Chart on Pressure ulcers - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 61: Data Table on Pressure ulcers - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 62: Chart on Pressure ulcers - Year-over-year growth 2023-2028 (%)
      • Exhibit 63: Data Table on Pressure ulcers - Year-over-year growth 2023-2028 (%)
    • 7.5 Venous leg ulcers - Market size and forecast 2023-2028
      • Exhibit 64: Chart on Venous leg ulcers - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 65: Data Table on Venous leg ulcers - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 66: Chart on Venous leg ulcers - Year-over-year growth 2023-2028 (%)
      • Exhibit 67: Data Table on Venous leg ulcers - Year-over-year growth 2023-2028 (%)
    • 7.6 Market opportunity by Application
      • Exhibit 68: Market opportunity by Application ($ billion)
      • Exhibit 69: Data Table on Market opportunity by Application ($ billion)

    8 Customer Landscape

    • 8.1 Customer landscape overview
      • Exhibit 70: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

    9 Geographic Landscape

    • 9.1 Geographic segmentation
      • Exhibit 71: Chart on Market share by geography 2023-2028 (%)
      • Exhibit 72: Data Table on Market share by geography 2023-2028 (%)
    • 9.2 Geographic comparison
      • Exhibit 73: Chart on Geographic comparison
      • Exhibit 74: Data Table on Geographic comparison
    • 9.3 North America - Market size and forecast 2023-2028
      • Exhibit 75: Chart on North America - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 76: Data Table on North America - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 77: Chart on North America - Year-over-year growth 2023-2028 (%)
      • Exhibit 78: Data Table on North America - Year-over-year growth 2023-2028 (%)
    • 9.4 Europe - Market size and forecast 2023-2028
      • Exhibit 79: Chart on Europe - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 80: Data Table on Europe - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 81: Chart on Europe - Year-over-year growth 2023-2028 (%)
      • Exhibit 82: Data Table on Europe - Year-over-year growth 2023-2028 (%)
    • 9.5 Asia - Market size and forecast 2023-2028
      • Exhibit 83: Chart on Asia - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 84: Data Table on Asia - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 85: Chart on Asia - Year-over-year growth 2023-2028 (%)
      • Exhibit 86: Data Table on Asia - Year-over-year growth 2023-2028 (%)
    • 9.6 Rest of World (ROW) - Market size and forecast 2023-2028
      • Exhibit 87: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 88: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 89: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
      • Exhibit 90: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
    • 9.7 US - Market size and forecast 2023-2028
      • Exhibit 91: Chart on US - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 92: Data Table on US - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 93: Chart on US - Year-over-year growth 2023-2028 (%)
      • Exhibit 94: Data Table on US - Year-over-year growth 2023-2028 (%)
    • 9.8 Germany - Market size and forecast 2023-2028
      • Exhibit 95: Chart on Germany - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 96: Data Table on Germany - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 97: Chart on Germany - Year-over-year growth 2023-2028 (%)
      • Exhibit 98: Data Table on Germany - Year-over-year growth 2023-2028 (%)
    • 9.9 UK - Market size and forecast 2023-2028
      • Exhibit 99: Chart on UK - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 100: Data Table on UK - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 101: Chart on UK - Year-over-year growth 2023-2028 (%)
      • Exhibit 102: Data Table on UK - Year-over-year growth 2023-2028 (%)
    • 9.10 France - Market size and forecast 2023-2028
      • Exhibit 103: Chart on France - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 104: Data Table on France - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 105: Chart on France - Year-over-year growth 2023-2028 (%)
      • Exhibit 106: Data Table on France - Year-over-year growth 2023-2028 (%)
    • 9.11 Japan - Market size and forecast 2023-2028
      • Exhibit 107: Chart on Japan - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 108: Data Table on Japan - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 109: Chart on Japan - Year-over-year growth 2023-2028 (%)
      • Exhibit 110: Data Table on Japan - Year-over-year growth 2023-2028 (%)
    • 9.12 Market opportunity by geography
      • Exhibit 111: Market opportunity by geography ($ billion)
      • Exhibit 112: Data Tables on Market opportunity by geography ($ billion)

    10 Drivers, Challenges, and Trends

    • 10.1 Market drivers
      • 10.2 Market challenges
        • 10.3 Impact of drivers and challenges
          • Exhibit 113: Impact of drivers and challenges in 2023 and 2028
        • 10.4 Market trends

          11 Vendor Landscape

          • 11.1 Overview
            • 11.2 Vendor landscape
              • Exhibit 114: Overview on Criticality of inputs and Factors of differentiation
            • 11.3 Landscape disruption
              • Exhibit 115: Overview on factors of disruption
            • 11.4 Industry risks
              • Exhibit 116: Impact of key risks on business

            12 Vendor Analysis

            • 12.1 Vendors covered
              • Exhibit 117: Vendors covered
            • 12.2 Market positioning of vendors
              • Exhibit 118: Matrix on vendor position and classification
            • 12.3 3M Co.
              • Exhibit 119: 3M Co. - Overview
              • Exhibit 120: 3M Co. - Business segments
              • Exhibit 121: 3M Co. - Key news
              • Exhibit 122: 3M Co. - Key offerings
              • Exhibit 123: 3M Co. - Segment focus
            • 12.4 B.Braun SE
              • Exhibit 124: B.Braun SE - Overview
              • Exhibit 125: B.Braun SE - Business segments
              • Exhibit 126: B.Braun SE - Key news
              • Exhibit 127: B.Braun SE - Key offerings
              • Exhibit 128: B.Braun SE - Segment focus
            • 12.5 Baxter Regional Medical Center
              • Exhibit 129: Baxter Regional Medical Center - Overview
              • Exhibit 130: Baxter Regional Medical Center - Key offerings
            • 12.6 Bioventus LLC
              • Exhibit 131: Bioventus LLC - Overview
              • Exhibit 132: Bioventus LLC - Business segments
              • Exhibit 133: Bioventus LLC - Key news
              • Exhibit 134: Bioventus LLC - Key offerings
              • Exhibit 135: Bioventus LLC - Segment focus
            • 12.7 Cardinal Health Inc.
              • Exhibit 136: Cardinal Health Inc. - Overview
              • Exhibit 137: Cardinal Health Inc. - Business segments
              • Exhibit 138: Cardinal Health Inc. - Key news
              • Exhibit 139: Cardinal Health Inc. - Key offerings
              • Exhibit 140: Cardinal Health Inc. - Segment focus
            • 12.8 Coloplast AS
              • Exhibit 141: Coloplast AS - Overview
              • Exhibit 142: Coloplast AS - Product / Service
              • Exhibit 143: Coloplast AS - Key offerings
            • 12.9 ConvaTec Group Plc
              • Exhibit 144: ConvaTec Group Plc - Overview
              • Exhibit 145: ConvaTec Group Plc - Product / Service
              • Exhibit 146: ConvaTec Group Plc - Key news
              • Exhibit 147: ConvaTec Group Plc - Key offerings
            • 12.10 DermaRite Industries LLC
              • Exhibit 148: DermaRite Industries LLC - Overview
              • Exhibit 149: DermaRite Industries LLC - Product / Service
              • Exhibit 150: DermaRite Industries LLC - Key offerings
            • 12.11 Integra Lifesciences Corp.
              • Exhibit 151: Integra Lifesciences Corp. - Overview
              • Exhibit 152: Integra Lifesciences Corp. - Business segments
              • Exhibit 153: Integra Lifesciences Corp. - Key news
              • Exhibit 154: Integra Lifesciences Corp. - Key offerings
              • Exhibit 155: Integra Lifesciences Corp. - Segment focus
            • 12.12 Johnson and Johnson
              • Exhibit 156: Johnson and Johnson - Overview
              • Exhibit 157: Johnson and Johnson - Business segments
              • Exhibit 158: Johnson and Johnson - Key news
              • Exhibit 159: Johnson and Johnson - Key offerings
              • Exhibit 160: Johnson and Johnson - Segment focus
            • 12.13 Medline Industries LP
              • Exhibit 161: Medline Industries LP - Overview
              • Exhibit 162: Medline Industries LP - Product / Service
              • Exhibit 163: Medline Industries LP - Key offerings
            • 12.14 Medtronic Plc
              • Exhibit 164: Medtronic Plc - Overview
              • Exhibit 165: Medtronic Plc - Business segments
              • Exhibit 166: Medtronic Plc - Key news
              • Exhibit 167: Medtronic Plc - Key offerings
              • Exhibit 168: Medtronic Plc - Segment focus
            • 12.15 Paul Hartmann AG
              • Exhibit 169: Paul Hartmann AG - Overview
              • Exhibit 170: Paul Hartmann AG - Business segments
              • Exhibit 171: Paul Hartmann AG - Key offerings
              • Exhibit 172: Paul Hartmann AG - Segment focus
            • 12.16 Smith and Nephew plc
              • Exhibit 173: Smith and Nephew plc - Overview
              • Exhibit 174: Smith and Nephew plc - Business segments
              • Exhibit 175: Smith and Nephew plc - Key news
              • Exhibit 176: Smith and Nephew plc - Key offerings
              • Exhibit 177: Smith and Nephew plc - Segment focus
            • 12.17 Zimmer Biomet Holdings Inc.
              • Exhibit 178: Zimmer Biomet Holdings Inc. - Overview
              • Exhibit 179: Zimmer Biomet Holdings Inc. - Business segments
              • Exhibit 180: Zimmer Biomet Holdings Inc. - Key news
              • Exhibit 181: Zimmer Biomet Holdings Inc. - Key offerings
              • Exhibit 182: Zimmer Biomet Holdings Inc. - Segment focus

            13 Appendix

            • 13.1 Scope of the report
              • 13.2 Inclusions and exclusions checklist
                • Exhibit 183: Inclusions checklist
                • Exhibit 184: Exclusions checklist
              • 13.3 Currency conversion rates for US$
                • Exhibit 185: Currency conversion rates for US$
              • 13.4 Research methodology
                • Exhibit 186: Research methodology
                • Exhibit 187: Validation techniques employed for market sizing
                • Exhibit 188: Information sources
              • 13.5 List of abbreviations
                • Exhibit 189: List of abbreviations

              Research Methodology

              Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

              INFORMATION SOURCES

              Primary sources

              • Manufacturers and suppliers
              • Channel partners
              • Industry experts
              • Strategic decision makers

              Secondary sources

              • Industry journals and periodicals
              • Government data
              • Financial reports of key industry players
              • Historical data
              • Press releases

              DATA ANALYSIS

              Data Synthesis

              • Collation of data
              • Estimation of key figures
              • Analysis of derived insights

              Data Validation

              • Triangulation with data models
              • Reference against proprietary databases
              • Corroboration with industry experts

              REPORT WRITING

              Qualitative

              • Market drivers
              • Market challenges
              • Market trends
              • Five forces analysis

              Quantitative

              • Market size and forecast
              • Market segmentation
              • Geographical insights
              • Competitive landscape

              Interested in this report?

              Get your sample now to see our research methodology and insights!

              Download Now

              Frequently Asked Questions

              Chronic Wound Care market growth will increase by $ 5.44 bn during 2024-2028 .

              The Chronic Wound Care market is expected to grow at a CAGR of 6.52% during 2024-2028 .

              Chronic Wound Care market is segmented by Product( Advanced dressing, Traditional wound care, Surgical wound care, Wound therapy devices) Application( Diabetic foot ulcers, Pressure ulcers, Venous leg ulcers)

              3M Co., B.Braun SE, Baxter Regional Medical Center, Bioventus LLC, Brightwake Ltd., Cardinal Health Inc., Coloplast AS, ConvaTec Group Plc, Essity AB, Integra Lifesciences Corp., Johnson and Johnson, Medline Industries LP, Medtronic Plc, Mil Laboratories Pvt. Ltd., MiMedx Group Inc., Paul Hartmann AG, Smith and Nephew plc, Welcare Industries SpA, Zimmer Biomet Holdings Inc., DermaRite Industries LLC are a few of the key vendors in the Chronic Wound Care market.

              North America will register the highest growth rate of 44% among the other regions. Therefore, the Chronic Wound Care market in North America is expected to garner significant business opportunities for the vendors during the forecast period.

              US, Germany, UK, France, Japan

              • Rising prevalence of chronic woundsThe global chronic wound care market is witnessing significant growth is the driving factor this market.
              • largely driven by the rising prevalence of chronic wounds worldwide. Chronic wounds are wounds that do not heal easily within a predictable timeframe is the driving factor this market.
              • typically persisting for more than three months. Some of the most common types of non-healing wounds: Diabetic foot ulcer: A diabetic foot ulcer is a wound that develops on a diabetics toes is the driving factor this market.
              • heels is the driving factor this market.
              • or feet. Due to nerve loss caused by diabetes is the driving factor this market.
              • people frequently have little to no feeling in their feet or the wound itself. If treatment is not received is the driving factor this market.
              • the damaged blood vessels cause the ulcer to become deeper and larger. Amputation is the driving factor this market.
              • hospitalization is the driving factor this market.
              • and infection are possible outcomes of this. Arterial or ischemic ulcer: When there is a lack of blood supply to the affected area is the driving factor this market.
              • an ischemic ulcer develops. These lesions are also known as ischemic ulcers since the medical word for inadequate blood supply is ischemia. The toes is the driving factor this market.
              • feet is the driving factor this market.
              • heels is the driving factor this market.
              • or ankles are the most common places to find them. Venous or stasis ulcer: Venous ulcers arise from blood clots in the veins brought on by malfunctioning valves that prevent blood from returning to the heart. These lesions are also known as venous stasis ulcers since the medical word for inadequate circulation is stasis. The most common location for them is immediately above the ankle. Pressure ulcer: Individuals with restricted mobility as a result of disease is the driving factor this market.
              • trauma is the driving factor this market.
              • or paralysis are particularly vulnerable to pressure ulcers. Those who are obese is the driving factor this market.
              • have poor diets is the driving factor this market.
              • or have bowel or urine incontinence are additional risk factors. Traumatic injury ulcer: Serious injuries or trauma can result in severe tissue loss and organ damage is the driving factor this market.
              • which can impair circulation and cause difficult-to-heal wounds. One of the main causes of traumatic injury-related chronic wounds is automobile accidents. If wound care after surgery is not successful is the driving factor this market.
              • surgical incisions may also result in a wound that is difficult to heal. Radiation-related wound: Another health issue that some cancer survivors deal with is a soft tissue injury or chronic wound that was brought on by their cancer therapy. Radiation can damage healthy tissues in addition to killing cancer cells. The damage may not show signs for months or even years after therapy concludes is the driving factor this market.
              • and it may increase over time. The frequency of chronic wounds is rising due to a number of variables. First and foremost is the driving factor this market.
              • the aging of the worlds population is significant because chronic wounds are more common in elderly people because of weakened healing abilities and underlying medical disorders. The aging population is growing due to improvements in healthcare and longer life expectancies is the driving factor this market.
              • which is increasing the occurrence of chronic wounds. Chronic wounds are also becoming more common as a result of the rising prevalence of non-communicable diseases like diabetes is the driving factor this market.
              • obesity is the driving factor this market.
              • and cardiovascular disorders. Diabetes and other related illnesses affect nerve activity and blood circulation is the driving factor this market.
              • which increases a patients risk of developing chronic wounds is the driving factor this market.
              • particularly foot ulcers. The need for goods and therapies for chronic wound care is rising as these diseases become more widespread globally. Non-healing wounds typically cause excruciating pain and make it difficult to carry out daily tasks. With specialized wound care is the driving factor this market.
              • the physician will investigate the reason(s) why the wound isnt healing and develop a plan of treatment to help begin the healing process and avoid more complications. A few of the following conditions can contribute to non-healing wounds: Age: Patients who are older recover more slowly and react less strongly to wounds. Stress: The pressure of immobility is the driving factor this market.
              • whether from a wheelchair is the driving factor this market.
              • bed or even an ill-fitting shoe is the driving factor this market.
              • can impede blood flow and the bodys natural healing process. Necrotic tissue: The wounds ability to heal may be hampered by dead skin that surrounds it and blocks blood flow. Medication: Anti-inflammatory medications is the driving factor this market.
              • such as Aleve or Advil is the driving factor this market.
              • lessen the inflammatory response that is required to support the skins cell regeneration. Weak immune system: Immune system weakness is a result of many diseases is the driving factor this market.
              • such as COPS is the driving factor this market.
              • diabetes is the driving factor this market.
              • and anemia is the driving factor this market.
              • which can hinder the healing process. Poor nutrition: The body needs a constant supply of vitamins is the driving factor this market.
              • proteins is the driving factor this market.
              • and minerals to effectively heal wounds. The body is less productive when it doesnt get enough of the ingredients it needs to cure itself. Incentives: Overindulgence in alcohol and tobacco usage hinders the healing of wounds and aggravates other health issues that interfere with natural wound healing. The availability of cutting-edge wound care products and technology is the driving factor this market.
              • coupled with growing patient and healthcare provider awareness of the significance of good wound treatment is the driving factor this market.
              • is propelling the global chronic wound care markets expansion. In order to provide cutting-edge treatments is the driving factor this market.
              • such as sophisticated dressings is the driving factor this market.
              • mechanical and biological wound therapies is the driving factor this market.
              • and negative pressure wound therapy devices is the driving factor this market.
              • businesses are investing in research and development. Thus is the driving factor this market.
              • the rising prevalence of chronic wounds will drive the growth of the global chronic wound care market during the forecast period. is the driving factor this market.

              The Chronic Wound Care market vendors should focus on grabbing business opportunities from the Advanced dressing segment as it accounted for the largest market share in the base year.